PubMed Health⌕ Search

Biomedical subjects

A V Beliavskiĭ

Publications and source records attributed to A V Beliavskiĭ.

At least 19 recordsLinked to original sources

[Biologic doses of sun ultraviolet in various geographic regions of Ukraine].

The values of minimal erytemal doses (MED) were determinated for solar ultraviolet (UV) for two geographic zones of Ukraine taking in account the seasons of a year. It was calculated a daily energetic loud produced by solar UV in summer for persons in outdoor. The idea concerning seasonal alternations of human individual sensitivity to solar UV was established.

Female↗

[A novel method of subtraction cDNA hybridization allowing cloning of genes showing differential expression in cell micropopulations].

A novel, efficient and simple technique that combines subtractive hybridization with kinetic enrichment is proposed for obtaining enriched cDNA. The method is based on the use of a set of special primers that allow for the selective amplification by PCR only of differentially distributed sequences. Using the proposed technique, cDNA of a new gene XEp-1, specifically expressed in the presumptive epidermis of Xenopus laevis, was cloned, starting with the stage of midgastrula.

Amino Acid Sequence↗

[Stem cells: properties and perspectives of therapeutic use].

In the present work, we review the properties of some stem cell types, namely embryonic, hematopoietic and mesenchymal stem cells, which present the most significant interest for use in medicine. Stem cells are undifferentiated cells capable of both self-maintenance and differentiation into mature specialized cells. According to their origin, stem cells can be classified as embryonic and somatic ones. The first ones can be indefinitely maintained in culture, and possess the ability to differentiate into all cells of the adult organism. The second ones possess the limited capacity to differentiate and, probably, a limited proliferative potential. For therapeutic use, important but hotly debated is the plasticity of somatic stem cells, i.e. context-dependent differentiation into "non-related" cell types. It is assumed that the differentiation of the majority of stem cell types proceeds according to the principle of stepwise hierarchical maturation through the stage of intermediate rapidly proliferating progenitor cells. The use of stem cells in medicine is mostly at the preclinical stage now. Despite the fact that embryonic stem cells are highly promising as therapeutic agents, a number of circumstances substantially limits their therapeutic use in the near future. At the same time, approaches involving autotransplantation of hematopoietic or mesenchymal stem cells are beginning to be applied successfully in the clinical trials for treatment of limb ischaemia and myocardial infarction. It is clear that despite a large number of problems and unsolved questions, the use of stem cells in medicine promises a dramatic progress in the treatment of many severe diseases.

Cell Differentiation↗

[Immunocytochemical study of the hcs2 gene products distribution in the command neurons of grape snail].

In the present study the cellular and subcellular distribution of putative protein products of hcs2 gene in the giant command neurons of parietal ganglia of the terrestrial snail Helix lucorum L. were investigated using light- and electron-microscopic immunocytochemistry. The product of hcs2 gene is a hybrid precursor protein belongs to the EF-hand family of the Ca(2+)-binding proteins, whose processed products are neuropeptides. By use of polyclonal antibodys against a synthetic CNP3, CNP4 and C-terminus peptide immunoreactivity was observed in the cytoplasmic secretory granules. The colloidal gold density in the granules for CNP3-4 neuropeptides was twice one for the Ca(2+)-binding protein. These immunocytochemical results point to a specific connection between putative protein products of hcs2 gene and the cell secretory apparatus, that correspond to our early expressed hypothesis that products of hcs2 gene act as neuromodulators or neurotransmitters.

Animals↗

[Molecular mechanisms of germ cell line determination in animals].

In the present work, principles of formation of germ line cells are reviewed. Germ line cells separate themselves from the rest of the embryo at the early stages of embryogenesis. In certain animal groups, formation of precursors of germ cells occurs by induction by surrounding cells. However, for most animal taxons, formation of primordial germ cells (PGCs) is determined by inheritance of certain maternal determinants--the so-called germ plasm. It is formed by mitochondria, electron-dense granules with the complex structure, and maternal RNAs and proteins necessary for formation of germ line. In Xenopus, the source of material for germ plasm is a mitochondrial cloud, which also specifically binds and transports to the vegetal pole maternal RNAs important for PGC formation. Cis elements determining the transport of these RNAs are usually located in the 3' untranslated region of RNA, and their function is mediated by binding of trans acting protein factors. In addition to a specific localization of certain macromolecules in germ plasm, special status of germ line cells is provided by degradation of RNA and protein components of germ plasm in somatic cells, silencing of transcription in PGCs until advanced stages of embryogenesis, and specific regulation of RNA translation in somatic and germ cells. In this review, we also briefly discuss results obtained by authors regarding the properties of a novel component of Xenopus germ plasm, namely maternal RNA germes, and encoded protein.

Animals↗

[Optimal chips for megabase DNA sequencing].

The SHOM method (Sequencing by Hybridization with Oligonucleotide Matrix) developed in 1988 is a new approach to nucleic acid sequencing by hybridization to a octanucleotide matrix composed of an array of immobilized oligonucleotides. The original matrix proposed for sequencing by SHOM had to contain at least 65,536 octanucleotides. The present work describes a new family of matrices for sequencing, which allows one to reduce the number of synthesized oligonucleotides 5-15 times without essentially decreasing the resolving power of the method.

Base Sequence↗